The U.S. Food and Drug Administration (FDA) has classified a nationwide recall involving 3,648 bottles of fenofibrate, a ...

A reported 3,600 bottles were pulled over "deviations" potentially affecting medication quality.

(Reuters) - Pfizer has agreed to pay $93 million to settle antitrust claims by wholesale drug distributors that accused it of conspiring with India's Ranbaxy Laboratories to delay sales of less ...

Sales of cholesterol blockbuster Lipitor plunged by half barely a week after the world's top-selling drug got its first U.S. generic competition, new data show. That's despite a very aggressive effort ...

A potential alternative to statins could help manage dangerously high cholesterol levels, according to scientists. Researchers have uncovered how elevated cholesterol dismantles the liver's natural ...

TRENTON, N.J. (AP) – Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some may contain tiny glass particles, the latest in a string ...

Problem-plagued Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into the ingredients used for dozens of ...

FILE - In this June 14, 2011 file photo, the drug Lipitor is displayed at Medco Health Solutions Inc., in Willingboro, N.J. Cholesterol blockbuster Lipitor is so valuable to Pfizer Inc. that the drug ...

Cholesterol-related heart disease remains the leading cause of death worldwide. The post Scientists find alternative drug to statins could help control cholesterol appeared first on Talker.

(Reuters) - The U.S. Food and Drug Administration confirmed on Wednesday that it had given approval to Ranbaxy Laboratories Ltd to make the first generic version of the cholesterol-lowering drug ...

TRENTON, N.J. -- Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor, because some may contain tiny glass particles, the latest in a string of ...